John Oroho moderated a panel entitled, “Implement a Scalable Aggregate Spend Solution,” at CBI’s 7th Annual Medical Device & Diagnostic Compliance Congress In Washington D.C. June 8. The points he covered in the program include:
- A comparison of state aggregate spend requirements of medical device vs. pharmaceutical companies.
- A sampling of the types of payments that need to be reported in different states.
- What information must be included, under the Federal Disclosure Law, on the Payments Transparency Report and on the Ownership Transparency Report
- Nevada’s Code of Conduct Laws
- California’s Comprehensive Compliance Program Law
- Connecticut’s Compliance Program and Code of Conduct
- Pending legislation in Massachusetts and Vermont
Mr. Oroho, Executive Vice President and Chief Strategy Officer of Porzio Pharmaceutical Services (PPS), who speaks at numerous conferences each year, is one of the most renowned experts on Aggregate Spend compliance at both the federal and individual state levels. PPS developed and licenses the industry’s most comprehensive and up-to-date compendium of information on pharmaceutical and medical device sales and marketing compliance in its robust, flagship product, Porzio Compliance Digest. It includes all the county, state and federal reporting laws concerning Aggregate Spend reporting whether from the recent enactment of the Physician Sunshine Payments provisions of the Patient Protection and Affordable Care Act (PPACA) or the ever-expanding state disclosure requirements. The company’s aggregate spend solution, Porzio AggregateSpendID, interfaces seamlessly with sales force automation (SFA), expense reimbursement (T&E) accounts payable (AP) and Enterprise Resource Planning (ERP) systems.
These are just a few examples of the home rule interpretation of state-specific aggregate spend compliance challenges faced by life sciences companies that Ms. Kim presented in this program.
Fortunately, Porzio Pharmaceutical Services created and maintains a database that tracks the bevy of laws in the user-friendly Porzio Compliance Digest that helps companies navigate and comply with the laws. It further includes an interactive map that a company’s personnel can use – by clicking on a state, a list of the applicable laws and regulations pops up. The Digest also provides a helpful comparison chart, “Aggregate Spend: State by State Overview.”
In addition, Porzio Pharmaceutical Services offers a robust aggregate spend compliance solution, Porzio AggregateSpendID, that provides an A-Z solution for pharmaceutical, medical device and biologics companies to deal with their aggregate spend obligation.